Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America. Its Dermatology products include Actikerall, Epuris, Ozanex and Vaniqa. Its Hospital Acute Care products include Aggrastat and Brinavess. Its Out-Licensed products include Absorica, ConZip and Lipofen. The Company is also focused on building a portfolio of prescription medicines that serve unmet medical needs. The Company's product pipeline development programs including MOB-015, DTR-001, and CF-101. The Company's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC, and Cipher Pharmaceuticals US LLC.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by nozzpackon Oct 04, 2021 9:04am

176 Views

Post# 33960047

Insider buying at $2.42…share buybacks

Filings by transaction date

Sep 20, 2021 (filed on Sep 20, 2021)

Insider Name:

Wolkin, Harold Morton

Ownership Type:

Direct Ownership

Securities:

Common Shares

Nature of Transaction:

30 - Acquisition or disposition under a purchase/ownership plan

# or value acquired/disposed of:

1,881

Price:

$2.42
Aug 31, 2021 (filed on Sep 13, 2021)

Insider Name:

Cipher Pharmaceuticals Inc.

Ownership Type:

Direct Ownership

Securities:

Common Shares

Nature of Transaction:

38 - Redemption, retraction, cancellation, repurchase

# or value acquired/disposed of:

-40,500

Price: